Symbicort 160mcg/4.5mcg Turbuhaler
Generic: Budesonide/Formoterolby AstraZeneca Pharma India Ltd

Select pack size
Similar medicines
View allAbout Symbicort 160mcg/4.5mcg Turbuhaler
Symbicort 160/4.5 Turbuhaler is AstraZeneca's budesonide and formoterol dry powder inhaler. Each inhalation delivers budesonide 160 mcg, an inhaled corticosteroid, and formoterol 4.5 mcg, a fast-acting, long-acting bronchodilator. The pack we sell is the Indian pack: 60 doses per inhaler, made in Sweden and marketed in India by Mankind Pharma under a distribution agreement with AstraZeneca. It is used for asthma and COPD. We sell it in packs of 1, 3 and 6 inhalers, from $25.00 an inhaler (about $0.42 a dose) in the 6 pack.
If you are in the US, read this first. The Symbicort 160/4.5 sold in the US is a pressurised aerosol inhaler (a puffer you shake and press). The Turbuhaler is a different device: a dry powder inhaler that you twist to load and then breathe in from hard. The FDA has not approved any budesonide with formoterol dry powder inhaler; every US product we found in FDA records is a metered aerosol. The numbers match on delivered dose, and a 12 week trial found the two devices worked equally well, but the technique is different, so do not switch without your prescriber.
This page covers what 160/4.5 and 200/6 mean, the price per inhaler and per dose, how the Turbuhaler compares with the US aerosol and generics, the three ways doctors prescribe it, how to use it, side effects, who should not use it and when to get urgent help. Clinical facts come from the UK Symbicort Turbohaler 200/6 product information and the Canadian Symbicort Turbuhaler product monograph, which cover this device, with US label facts named as such. Sources are listed at the end.
Symbicort 160/4.5 Turbuhaler at a glance
| Active ingredients | Budesonide 160 mcg and formoterol fumarate dihydrate 4.5 mcg per delivered dose (the UK and Canadian labels give the metered dose of the same strength as 200 mcg and 6 mcg) |
| Brand and maker | Symbicort, AstraZeneca. Indian listings give Sweden as the country of origin (Apollo, Truemeds, PharmEasy) and Mankind Pharma as the Indian marketer (Tata 1mg, Apollo, Netmeds) |
| Device | Turbuhaler (called Turbohaler in the UK): a breath-driven dry powder inhaler with a dose indicator. Indian pack: 60 doses |
| Used for | Asthma in adults and adolescents aged 12 and over; COPD in adults aged 18 and over (UK and Canadian labels) |
| Regulatory status | Symbicort Turbuhaler 200/6 is licensed in the UK, Canada and Australia. In the US only the aerosol form of budesonide with formoterol is approved. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada. |
| Usual dose from the UK label | Asthma maintenance: 1 to 2 inhalations twice a day. COPD: 2 inhalations twice a day. Doctors can also prescribe it as maintenance and reliever, or as a reliever alone for mild asthma, with daily limits (see below) |
| Timing | Formoterol starts to open the airways within 1 to 3 minutes and lasts at least 12 hours after a single dose (UK label 5.1) |
| Packs | 1, 3 and 6 inhalers of 60 doses |
| Price | $30.00 (1 inhaler) down to $25.00 (6 pack) per inhaler; $0.50 down to $0.42 per dose, before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per inhaler and per dose
Prices below are as of October 2026; the pack selector shows the current price.
| Pack | Price | Per inhaler | Per dose (60 per inhaler) | Shipping | Per inhaler with shipping |
|---|---|---|---|---|---|
| 1 inhaler | $30 | $30.00 | $0.50 | $25 | $55.00 |
| 3 inhalers | $80 | $26.67 | $0.44 | $25 | $35.00 |
| 6 inhalers | $150 | $25.00 | $0.42 | Free | $25.00 |
The 6 pack is the cheapest per inhaler before shipping as well as after; free shipping widens the gap. A single inhaler with $25 shipping costs almost twice the inhaler price.
How long a pack lasts. Each Indian inhaler holds 60 doses, half the 120 doses of a US Symbicort aerosol. At 1 inhalation twice a day one inhaler lasts 30 days; at 2 inhalations twice a day it lasts 15 days. So a 3 pack covers about 45 to 90 days and a 6 pack about 90 to 180 days of maintenance use. If your doctor has you using it as a reliever as well, extra inhalations make it run out sooner (our arithmetic).
Turbuhaler or the US Symbicort inhaler: what 160/4.5 means
Budesonide with formoterol strengths are written in two ways, which is why the same medicine appears as 160/4.5 in one place and 200/6 in another:
- Metered dose: what the device measures out. The UK labels this Turbohaler 200/6 and Canada calls it Symbicort 200 Turbuhaler.
- Delivered dose: what leaves the mouthpiece. The UK product information says each delivered dose of the 200/6 Turbohaler contains budesonide 160 mcg and formoterol 4.5 mcg, and the Canadian monograph says the same. Indian listings name this pack 160/4.5, which matches the delivered dose; we have not seen the Indian carton state whether its numbers are metered or delivered.
The US Symbicort 160/4.5 aerosol is labelled by delivered dose too: its metered dose is 181/5.1. So the US aerosol and this Turbuhaler match on delivered dose per inhalation, not on device.
| Symbicort 160/4.5 Turbuhaler (this pack) | Symbicort 160/4.5 aerosol (US) | |
|---|---|---|
| Device | Dry powder inhaler, breath-driven | Pressurised metered dose inhaler |
| Delivered dose per inhalation | 160 mcg / 4.5 mcg | 160 mcg / 4.5 mcg |
| Doses per inhaler | 60 (Indian pack); the UK label lists 30, 60 and 120 | 120 (also a 60 dose canister) |
| Before each dose | Twist the grip to load; do not shake to load | Shake for 5 seconds; prime before first use |
| How to breathe in | "Breathe in forcefully and deeply" (UK label) | Breathe in deeply and slowly while pressing the canister (US label) |
| Contains lactose | Yes, under 1 mg per inhalation (milk protein traces) | No |
| Licensed as a reliever | Yes in the UK and Canada, within daily limits | No: the US label says it is "NOT indicated for the relief of acute bronchospasm" |
In a 12 week double-blind trial of 680 people aged 12 and over with asthma, two inhalations twice a day of budesonide with formoterol 160/4.5 gave "therapeutically equivalent" gains in morning peak flow from the aerosol (29.3 L/min) and the Turbuhaler (32.0 L/min), and both were similarly well tolerated (Morice 2007). That supports the two devices doing the same job at the same dose. It does not make technique interchangeable: a dry powder inhaler needs a fast, deep breath, and some people, especially during a bad attack, may not be able to breathe in hard enough (our note). Ask a doctor, nurse or pharmacist to check that you can use it before you rely on it.
Compared with US Symbicort and US generics
| Symbicort 160/4.5 Turbuhaler (ours) | Symbicort 160/4.5 aerosol (US) | US generic budesonide and formoterol 160/4.5 | |
|---|---|---|---|
| Maker | AstraZeneca (Indian pack, made in Sweden) | AstraZeneca | AstraZeneca authorised generic; Teva; Breyna (Mylan) |
| Device | Dry powder inhaler, 60 doses | Aerosol, 120 inhalations | Aerosols; no US dry powder version |
| FDA approved | No | Yes | Yes |
| Cost per inhaler | $25.00 to $30.00 before shipping | About $224 (NADAC $21.98051 per gram) | About $177 (NADAC $17.31907 per gram, authorised generic and Teva); Breyna $20.53306 per gram |
| Cost per inhalation | $0.42 to $0.50 before shipping | About $1.87 | About $1.47 |
NADAC is what US pharmacies pay to buy the medicine, not what you pay at the counter. The NADAC rows are effective 21 October 2026 (checked 28 October 2026). The per inhaler figures are our arithmetic: the per gram rate times the 10.2 g fill of a 120 inhalation canister given in the US label. We did not check Breyna's fill weight. Per dose, our Turbuhaler costs less than US pharmacies pay for the aerosol, but it is a different device that your US prescription does not name. If you have insurance or a manufacturer savings card, compare your copay first.
In the UK, AstraZeneca lists the basic NHS cost of Symbicort Turbohaler 200/6 as £28.00 for 120 doses, about 23p a dose (our arithmetic). In Australia the PBS dispensed price for Symbicort Turbuhaler 200/6, 120 actuations, under item 12041R (the mild asthma listing) is A$41.53, and a general patient pays A$28.88 including the brand premium. With a local prescription, the UK and Australian routes cost less per dose than ours, come from a registered pharmacy and do not take 7 to 14 days.
Which strength to choose
| Product | Delivered (metered) dose | What the UK and Canadian labels allow it for |
|---|---|---|
| Symbicort 80/4.5 Turbuhaler | 80/4.5 (100/6) | Lower strength for asthma maintenance and for maintenance and reliever therapy. The UK licenses it from age 6; Canada from age 12 |
| Symbicort 160/4.5 Turbuhaler (this page) | 160/4.5 (200/6) | Asthma maintenance; maintenance and reliever; reliever alone for mild asthma (UK, Canada). COPD in adults. 12 and over for asthma |
| Symbicort 320/9 Turbuhaler | 320/9 (400/12) | Maintenance only. Canada says it should NOT be used for reliever or maintenance and reliever therapy; it is licensed for COPD there |
160/4.5 is the only Turbuhaler strength licensed in both the UK and Canada as a reliever on its own. The Global Initiative for Asthma (GINA) counts budesonide by metered dose: 200 to 400 mcg a day is low, above 400 to 800 mcg is medium and above 800 mcg is high for adults and adolescents (GINA 2026 Summary Guide, Table 6). On that scale, one inhalation of this strength twice a day is 400 mcg (low) and two twice a day is 800 mcg (top of medium). The steroid dose should be the lowest that keeps your asthma controlled, so a change of strength is a decision for your doctor.
The same medicine also comes in Indian Cipla inhalers we sell: Foracort 200 Inhaler (pressurised, 120 puffs), Foracort 200 Synchrobreathe (breath-actuated) and Foracort 200 Rotacap (capsule dry powder). They carry the same 200/6 numbers but are different products from a different maker; we have not found a published study comparing them with Symbicort.
Three ways doctors prescribe it
The UK and Canadian labels license three approaches for asthma. Which one you follow, and your daily limit, should be in your written asthma action plan.
- Maintenance only, with a separate reliever. UK: adults 1 to 2 inhalations twice a day, and "some patients may require up to a maximum of 4 inhalations twice daily"; adolescents 12 to 17, 1 to 2 inhalations twice a day. Canada: 1 or 2 inhalations once or twice a day, maximum 4 a day, which may be raised for a time to up to 4 twice a day while asthma is worse. Keep a separate fast reliever, such as salbutamol, with you at all times.
- Maintenance and reliever therapy (MART; called SMART in Canada). A daily maintenance dose (UK: usually 2 inhalations a day; some patients 2 twice a day), plus 1 extra inhalation when symptoms come, and another after a few minutes if needed. UK: "Not more than 6 inhalations should be taken on any single occasion." A total above 8 a day "is not normally needed", up to 12 a day "could be used for a limited period", and patients using more than 8 a day "should be strongly recommended to seek medical advice". Canada: "The maximum recommended total daily dose is 8 inhalations."
- Reliever only, for mild asthma. 1 inhalation as needed, another after a few minutes if symptoms persist, not more than 6 on one occasion. Same 8 and 12 a day limits as above (UK), but here the UK label says people using more than 8 a day "should be reassessed for alternative explanations of persisting symptoms"; maximum 8 a day (Canada).
For COPD the labels license maintenance only: 2 inhalations twice a day (UK), with a maximum of 4 a day (Canada).
GINA, an international asthma strategy group, calls the reliever approach "Track 1": "The preferred treatment, in which the reliever is low-dose ICS-formoterol". It says GINA recommends Track 1 "because there is strong evidence that it reduces the risk of severe exacerbations, compared with Track 2, with similar symptom control", and that patients should get medical care if they need "more than total 12 inhalations" in 24 hours (GINA 2026 Summary Guide). Using this inhaler as a reliever is a plan your doctor sets with you; do not start it on your own, and do not use it as a reliever if your maintenance inhaler contains a different long-acting bronchodilator such as salmeterol.
What the evidence says
- Maintenance and reliever. The UK label reports 5 double-blind studies of 12,076 people with asthma, 6 to 12 months long; maintenance and reliever therapy cut severe exacerbations in every comparison. In the 12 month study 734, severe exacerbations were 0.19 per patient-year with Symbicort as maintenance and reliever, against 0.29 with a formoterol reliever and 0.37 with a terbutaline reliever at the same maintenance dose.
- Reliever only in mild asthma. In SYGMA 2 (12 months, 4,167 people in the two arms shown), as-needed budesonide with formoterol 160/4.5 gave a severe exacerbation rate of 0.11 per patient-year against 0.12 with twice daily budesonide plus a terbutaline reliever, with a 75% lower median inhaled steroid load. In the SYGMA studies, asthma control scores and lung function improved slightly less than with daily budesonide; the label calls the control differences not clinically meaningful and the lung function differences small (about 30 to 55 mL), and notes that trial adherence to daily budesonide was "considerably higher" than expected in real life.
- COPD. In two 12 month studies of people with moderate to severe COPD (lung function below 50% of predicted before a bronchodilator), exacerbations fell to 1.4 a year from 1.8 to 1.9 with formoterol alone or placebo; lung function was not better than with formoterol alone (UK label 5.1).
How to use the Turbuhaler
These steps come from the UK Symbicort Turbohaler patient leaflet. Follow the leaflet in your pack if it differs. Some Indian pharmacy listings (Tata 1mg, for example) describe shaking the inhaler and pressing down on it to release the medicine: that is aerosol text and does not apply to a Turbuhaler.
- Prepare a new inhaler once. Unscrew and lift off the cover. Hold it upright with the red grip at the bottom, turn the grip as far as it goes one way, then back the other way until it clicks. Do this twice. It is then ready, and you do not repeat this before each dose.
- Load a dose. Hold it upright and turn the grip one way and back until it clicks. Load only when you are about to use it, and do not hold the mouthpiece while loading.
- Breathe out gently, away from the inhaler. Never breathe out into it.
- Breathe in hard. Put the mouthpiece between your teeth, close your lips and breathe in as deeply and as hard as you can. You may not taste or feel anything; the dose is very small (UK label 4.2).
- Remove it and breathe out gently. For a second inhalation, load again and repeat.
- Replace the cover tightly after use. Canada says to store it with the cover tightened.
- Rinse your mouth with water after your morning and evening doses and spit it out, to lower the risk of thrush. If thrush occurs, rinse after reliever doses too (UK label).
- Watch the dose indicator. A red mark appears with about 20 doses left; the background turns red for the last 10. When the 0 reaches the middle of the window, start a new inhaler. The grip still clicks when it is empty, and the rattle you hear when you shake it is a drying agent, not medicine.
- Clean it weekly by wiping the outside of the mouthpiece with a dry tissue. Do not use water.
- If you miss a dose, take it when you remember unless the next dose is nearly due; do not take a double dose (UK leaflet).
Take maintenance doses every day, even when you feel well. Do not stop suddenly: the UK label says the dose should be tapered when treatment is stopped.
Groups who need care with the dose
- Children: this strength is for age 12 and over in asthma (UK, Canada). The UK licenses the 100/6 Turbohaler from age 6. The UK label says MART and reliever-only use are not recommended for children under 12.
- Older people: no special dosing (UK label).
- Liver disease: both medicines are cleared mainly by the liver; the UK label says more exposure "can be expected in patients with severe liver cirrhosis".
- Kidney disease: the UK label says there are no data.
- Strong CYP3A4 inhibitors (for example itraconazole, ketoconazole, ritonavir and other HIV protease inhibitors, clarithromycin): the UK label says they are likely to markedly raise budesonide levels and the combination "should be avoided"; if that is not possible, space the doses as far apart as possible. "In patients using potent CYP3A4 inhibitors, Symbicort maintenance and reliever therapy is not recommended."
Side effects
The UK label says the most common reactions are the predictable effects of formoterol, such as tremor and palpitations, which "tend to be mild and usually disappear within a few days of treatment". Selected rows from the UK table (section 4.8):
| Frequency (UK label) | Reactions |
|---|---|
| Common (1 to 10 in 100) | Thrush in the mouth and throat; pneumonia in people with COPD; headache; tremor; palpitations; mild throat irritation; cough; hoarseness |
| Uncommon (1 to 10 in 1,000) | Aggression, overactivity, anxiety, sleep problems; dizziness; blurred vision; fast heartbeat; nausea; bruising; muscle cramps |
| Rare (1 to 10 in 10,000) | Allergic reactions including rash, hives, itching, swelling (angioedema) and anaphylaxis; low potassium; irregular heart rhythms; bronchospasm |
| Very rare (under 1 in 10,000) | Cushing's syndrome, adrenal suppression, slowed growth, reduced bone density; high blood sugar; depression and behaviour changes (mainly in children); taste changes; cataract and glaucoma; angina; QTc prolongation; changes in blood pressure |
With long-term use, especially at high doses, inhaled steroids can affect the adrenal glands, bones, eyes and children's growth; the UK label advises regular height checks in children on long-term treatment and an eye referral for blurred vision. In COPD, inhaled steroids raise the risk of pneumonia, and its signs overlap with a COPD flare. The US aerosol label gives trial percentages for the aerosol form; we have not repeated them here because this page is about the Turbuhaler.
When to get urgent help
- A severe asthma or COPD attack, or one that does not ease with your reliever: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia). If you use this inhaler as your reliever and 6 inhalations on one occasion have not helped, treat it as an emergency (our advice, based on the UK single-occasion limit).
- Wheezing or breathlessness that gets worse straight after an inhalation (paradoxical bronchospasm): use a fast-acting reliever and get medical help. The UK label says Symbicort "should be discontinued immediately" and the patient assessed.
- Needing more inhalations than usual, or the inhaler working less well: the UK label says "medical attention must be sought". On maintenance and reliever therapy, more than 8 inhalations a day needs medical advice (UK), and GINA says get medical care if you need more than 12 in 24 hours.
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, rash or hives: signs of an allergic reaction. Stop the inhaler and get help right away. This includes a reaction to the milk proteins in lactose.
- Chest pain, a very fast or irregular heartbeat, fainting or a fit.
- Taking far more inhalations than prescribed: the UK label says a formoterol overdose would likely cause tremor, headache and palpitations, and lists fast heartbeat, high blood sugar, low potassium, QTc prolongation, heart rhythm changes, nausea and vomiting from isolated cases.
- Signs of adrenal crisis after a recent fast cut in steroids, or during severe illness or surgery after long high-dose use: the UK label lists loss of appetite, stomach pain, weight loss, tiredness, headache, nausea, vomiting, reduced consciousness, seizures, low blood pressure and low blood sugar.
Tell the emergency staff which inhaler you use, how many inhalations you took and when.
Who should not use Symbicort Turbuhaler
Never use it (contraindications) if you are allergic to budesonide, formoterol or lactose. The UK label adds that the lactose contains small amounts of milk proteins; Canada names "inhaled lactose". The lactose amount (under 1 mg per inhalation) "does not normally cause problems in lactose intolerant people" (UK label); a milk protein allergy is different.
Do not start it during an asthma attack or when asthma is worsening fast: the UK label says patients "should not be initiated on Symbicort during an exacerbation". The Canadian monograph says it is not indicated for acute bronchospasm in COPD.
Talk to a doctor first (UK label 4.4 and 4.5 unless stated):
- Overactive thyroid, phaeochromocytoma, diabetes, untreated low potassium, hypertrophic obstructive cardiomyopathy, idiopathic subvalvular aortic stenosis, severe high blood pressure, aneurysm or other severe heart disease such as ischaemic heart disease, fast heart rhythms or severe heart failure; a long QTc interval.
- Active or quiescent lung tuberculosis, or fungal or viral airway infections: the need for, and dose of, the inhaled steroid should be re-evaluated.
- Switching from steroid tablets: adrenal function may stay impaired "for a considerable time".
- Beta blockers, including eye drops: Symbicort "should therefore not be given together with beta-adrenergic blockers (including eye drops) unless there are compelling reasons".
- MAO inhibitors (hypertensive reactions); quinidine, disopyramide, procainamide, phenothiazines, terfenadine and tricyclic antidepressants (QTc and arrhythmias); digitalis glycosides when potassium is low (arrhythmias); xanthine derivatives such as theophylline, steroids and diuretics (low potassium); L-dopa, L-thyroxine, oxytocin and alcohol (lower heart tolerance of formoterol); general anaesthesia with halogenated hydrocarbons (arrhythmias).
- Pregnancy: "Symbicort should only be used when the benefits outweigh the potential risks", at the lowest effective budesonide dose. Poorly controlled asthma also carries risks in pregnancy.
- Breastfeeding: budesonide passes into breast milk, though no effects on the baby are expected at usual doses; use "should only be considered if the expected benefit to the mother is greater than any possible risk to the child".
Prescription and legal status
Symbicort Turbohaler 200/6 is a prescription-only medicine in the UK (PL 17901/0092). Symbicort 200 Turbuhaler is a prescription medicine in Canada (DIN 02245386, marketed since 2002). In Australia, Symbicort Turbuhaler 200/6 is Schedule 4 (prescription only) and on the PBS. In the US, budesonide with formoterol is a prescription medicine, and every approved product we found in FDA records (Symbicort, its authorised generic, Breyna and Teva's generic) is a metered aerosol; we found no FDA-approved budesonide with formoterol dry powder inhaler. Indian listings mark this pack as prescription only (Apollo, Tata 1mg, Truemeds, Netmeds). This Indian pack is not registered with the FDA, the MHRA, the TGA or Health Canada. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances. Asthma and COPD need regular review by a doctor or nurse, including an inhaler technique check and a written action plan. Check the rules where you live.
Buying genuine Symbicort Turbuhaler
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers this Indian pack, and UK readers can get the UK-licensed Turbohaler on an NHS prescription.
When your order arrives, check that the carton names Symbicort Turbuhaler 160/4.5, AstraZeneca and 60 doses, shows a batch number and an expiry date, and that the dose indicator starts at the full count. These checks cannot prove an inhaler is genuine, because counterfeiters copy packaging. If an inhaler does not seem to control your symptoms the way your previous one did, see your doctor rather than taking extra inhalations. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Storage: the UK label says it needs no special storage conditions; the Canadian monograph says store at 15 to 30 C with the cover tightened. Indian listings say store below 30 C (Tata 1mg, Truemeds) or at 20 to 25 C (Apollo). It does not need a fridge. Keep it dry, away from heat and out of children's reach.
Delivery
We ship Symbicort Turbuhaler to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries, so order at least three weeks before your current inhaler runs out; a 60 dose inhaler can last as little as 15 days at the full maintenance dose. Shipping costs a flat $25 on orders under $149 and is free from $149, so the 6 pack ships free. See our shipping page and refund policy.
Related guides
- Budesonide with formoterol inhalers: doses, MART and what the trials show
- Advair vs Symbicort (Seroflo vs Foracort): which combination inhaler
- Rotacaps vs inhaler vs respules: which device gets the dose into your lungs
- Prednisolone for asthma flare-ups: dose, course length and risks
- Breztri vs Trelegy: triple inhalers for COPD and asthma
Sources
- Symbicort Turbohaler 200/6 inhalation powder. UK summary of product characteristics, AstraZeneca UK, revised 21 March 2023, sections 2, 4.1 to 4.9, 5.1, 5.2, 6.1, 6.4 and 6.5. emc
- Symbicort Turbohaler 200/6. UK patient information leaflet, revised August 2023. emc
- Symbicort Turbuhaler product monograph, AstraZeneca Canada, revised 8 February 2021: indications, contraindications, dosage and administration, storage, composition. Health Canada; Drug Product Database, Symbicort 200 Turbuhaler, DIN 02245386, checked 28 October 2026.
- Budesonide and formoterol fumarate dihydrate inhalation aerosol (AstraZeneca, the Symbicort formulation), US prescribing information, DailyMed version of December 2025, sections 1, 2, 5 and 16. DailyMed
- US Food and Drug Administration. Drugs@FDA records for budesonide with formoterol (NDA021929, ANDA211699, ANDA212212), via openFDA, checked 28 October 2026.
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), 2026 file, as of 28 October 2026: Symbicort 160/4.5 (NDC 00186037020), budesonide-formoterol 160/4.5 (NDC 00310737020, 00480308131) and Breyna 160/4.5 (NDC 00378750332), each effective 21 October 2026. data.medicaid.gov
- Global Initiative for Asthma. Summary Guide for Asthma Management and Prevention 2026 (published July 2026), Track 1, Table 6 and Table 7. ginasthma.org
- Morice AH, et al. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract. 2007. PMID 17887990.
- AstraZeneca UK. Symbicort asthma licence and dosing guide, prescribing information with basic NHS cost, prepared August 2025. myastrazeneca.co.uk
- Pharmaceutical Benefits Scheme. Budesonide + formoterol, item 12041R, accessed 28 October 2026. pbs.gov.au; healthdirect, Symbicort Turbuhaler 200/6 (Schedule 4, PBS verified 1 October 2026). healthdirect
- Tata 1mg, Apollo Pharmacy, Truemeds, PharmEasy and Netmeds. Symbicort 160/4.5 Turbuhaler 60 dose listings, accessed 28 October 2026. Tata 1mg, Apollo, Truemeds, PharmEasy, Netmeds
- AstraZeneca Pharma India. AstraZeneca Pharma India Ltd and Mankind Pharma partner to accelerate access to asthma medicine for patients in India (exclusive distribution of Symbicort in India; AstraZeneca remains marketing authorisation holder and import licence holder), 11 March 2024. astrazeneca.com
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Budesonide with formoterol is a prescription medicine; your doctor should set your dose, your inhaler and your asthma or COPD action plan.
Frequently asked questions
What is Symbicort 160/4.5 Turbuhaler?
It is AstraZeneca's budesonide and formoterol dry powder inhaler. Each inhalation delivers budesonide 160 mcg, an inhaled steroid, and formoterol 4.5 mcg, a fast-acting, long-acting bronchodilator. The pack we sell is the Indian pack of 60 doses, which Indian listings say is made in Sweden and marketed in India by Mankind Pharma. It is used for asthma from age 12 and for COPD in adults. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada.
Is it the same as the Symbicort 160/4.5 inhaler sold in the US?
Same medicine and same delivered dose per inhalation, different device. The US Symbicort 160/4.5 is a pressurised aerosol you shake and press; the Turbuhaler is a dry powder inhaler you twist to load and breathe in from hard. The FDA has not approved any budesonide with formoterol dry powder inhaler. A 12 week trial of 680 people found the two devices therapeutically equivalent at two inhalations twice a day (Morice 2007), but the technique differs, so do not switch without your prescriber.
Why is it called 160/4.5 here and 200/6 in the UK?
The UK and Canada label this Turbuhaler by its metered dose, 200 mcg budesonide and 6 mcg formoterol, and state that each delivered dose (what leaves the mouthpiece) is 160 mcg and 4.5 mcg. Indian listings use 160/4.5, the same numbers as the delivered dose, though we have not seen the Indian carton say whether its numbers are metered or delivered; the US labels its aerosol by delivered dose. It is the same strength written two ways.
What does Symbicort 160/4.5 Turbuhaler cost?
As of October 2026 it costs $30 for one inhaler, $80 for three ($26.67 each) and $150 for six ($25.00 each), or $0.42 to $0.50 per dose before shipping; the pack selector shows the current price. Shipping is $25 under $149 and free from $149, so the 6 pack ships free. UK NHS and Australian PBS prices per dose are lower than ours for people with a local prescription.
How long does one inhaler last?
The Indian inhaler holds 60 doses. At 1 inhalation twice a day it lasts 30 days; at 2 inhalations twice a day it lasts 15 days (our arithmetic). Extra reliever inhalations, if your doctor has set that up, make it run out sooner. With 7 to 14 business days for delivery, order well before you run out.
How do I use the Turbuhaler?
Before the first use, turn the red grip fully one way and back twice. For each dose, hold it upright, turn the grip one way and back until it clicks, breathe out away from the inhaler, then seal your lips on the mouthpiece and breathe in as deeply and as hard as you can. Do not shake it to load and never breathe out into it. Replace the cover and rinse your mouth after your morning and evening doses (UK leaflet).
Can I use it as a reliever?
Only if your doctor prescribes it that way. The UK and Canadian labels license this strength as maintenance and reliever therapy and as a reliever alone for mild asthma: 1 inhalation as needed, another after a few minutes, not more than 6 on one occasion. Above 8 a day, the UK label says people on maintenance and reliever therapy should be strongly recommended to seek medical advice, and people using it as a reliever only should be reassessed; Canada sets 8 a day as the maximum. GINA prefers this approach for adults and adolescents. The US aerosol is not licensed as a reliever.
Which strength should I use?
Your doctor decides. 160/4.5 sits between the 80/4.5 and 320/9 Turbuhalers, and it is the only Turbuhaler strength licensed in the UK and Canada as a reliever on its own. At 2 inhalations twice a day it gives 800 mcg of budesonide (metered), the top of GINA's medium dose band. The steroid dose should be the lowest that keeps your asthma controlled.
What are the side effects?
The UK label lists thrush in the mouth and throat, headache, tremor, palpitations, throat irritation, cough and hoarseness as common, and pneumonia as common in people with COPD. Tremor and palpitations are usually mild and pass within a few days. Rinsing your mouth after doses lowers the thrush risk. Long-term high doses can affect the adrenal glands, bones, eyes and children's growth.
Who should not use it?
Anyone allergic to budesonide, formoterol or lactose, which contains small amounts of milk proteins (UK and Canadian labels). It should not be started during an asthma attack. Talk to a doctor first if you have heart disease, a long QTc interval, an overactive thyroid, diabetes, low potassium, tuberculosis, are pregnant or breastfeeding, take beta blockers (including eye drops), MAO inhibitors or strong CYP3A4 inhibitors such as itraconazole or ritonavir.
Do I need a prescription, and how is it delivered?
It is a prescription medicine in the US, UK, Canada and Australia, and Indian listings mark this pack as prescription only. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances. We ship to the US, UK, Australia and Canada in plain packaging with tracking, in 7 to 14 business days; shipping is $25 under $149 and free from $149.
Medical References
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Symbicort 160mcg/4.5mcg Turbuhaler? Tell other buyers how it went.







